ArticleInvestigational new drugs2022

Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer.

Hisanaga Nomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.